Amir Reichman is the founder of BiondVax. BiondVax has raised $30M in total funding. Latest round: Growth. Based in Rehovot, Israel.
Amir Reichman is the CEO of BiondVax Pharmaceuticals Ltd., a biopharmaceutical company specializing in developing innovative therapies, including an inhaled NanoAb for COVID-19. He has restructured the company and led several capital raises, securing millions in funding for its new mission.
Full founder directory · Investor directory · Company funding database · Fundraising library